No
|
MOG-IgG1
|
MOG-IgG
|
MOG-IgM
|
MOG-IgA
|
Disease status
|
---|
1
|
POS
|
POS
|
NEG
|
NEG
|
Relapse
|
2
|
POS
|
POS
|
NEG
|
NEG
|
Relapse
|
3A
|
POS
|
POS
|
NEG
|
NEG
|
Relapse
|
3B
|
POS
|
POS
|
NEG
|
NEG
|
Remission
|
4
|
POS
|
POS
|
NEG
|
NEG
|
Remission
|
5
|
POS
|
POS
|
NEG
|
NEG
|
Remission
|
6
|
POS
|
POS
|
NEG
|
NEG
|
Remission
|
7
|
POS
|
POS
|
NEG
|
NEG
|
Remission
|
8
|
POS
|
POS
|
NEG
|
NEG
|
Relapse
|
9A
|
POS
|
POS
|
NEG
|
NEG
|
Relapse
|
9B
|
n.d.
|
POS
|
NEG
|
NEG
|
Remission
|
10A
|
POS
|
POS
|
NEG
|
NEG
|
Relapse
|
10B
|
n.d.
|
POS
|
NEG
|
NEG
|
Remission
|
11
|
n.d.
|
POS
|
NEG
|
NEG
|
Relapse
|
12
|
n.d.
|
POS
|
NEG
|
NEG
|
Remission
|
13
|
n.d.
|
POS
|
NEG
|
NEG
|
Remission
|
14A
|
n.d.
|
POS 1:1000
|
POS 1:20
|
NEG
|
Relapse
|
14B
|
n.d.
|
POS 1:100
|
POS 1:10
|
NEG
|
Remission
|
15A
|
n.d.
|
POS
|
NEG
|
NEG
|
Remission
|
15B
|
n.d.
|
POS
|
NEG
|
NEG
|
Remission
|
16
|
POS
|
POS
|
n.d.
|
n.d.
|
Relapse
|
17
|
POS
|
POS
|
n.d.
|
n.d.
|
Relapse
|
18
|
POS
|
POS
|
n.d.
|
n.d.
|
Relapse
|
- MOG-IgG was determined using a commercial fixed CBA (cut-off 1:10). MOG-IgG1 was also present in 3/3 CSF samples from MOG-IgG1-seropositive patients (not shown). POS positive, NEG negative, n.d not done